Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

METiS Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

16 investors on METiS Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 6 investors entered at this stage
Source Code Capital
Sequoia
Luminous Ventures
XtalPi
Shanghai Ziyou Investment Management
Lightspeed Venture Partners
Series A 5 investors entered at this stage
HongShan
China Life Insurance
5Y Capital
China Life Private Equity Investment
Picc Group
Series B+ 5 investors entered at this stage
CMB International Capital
CICC
Monolith Management
PICC Capital
China Taiping Insurance

Global footprint

Where METiS Therapeutics has talent and traffic

Web traffic by country
1.9K monthly visits
across markets
🇺🇸 United States94.7%
🇮🇳 India5.3%
Top 2 markets shown

See METiS Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo